Simvastatin 13CD3 | CAS 1261364-93-5 - Request Quote
Simvastatin 13CD3
| SZ CAT No: | SZ-S008D06 |
| CAS No | 1261364-93-5 |
| Mol.F. | C2413CH35D3O5 |
| Mol.Wt. | 422.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Simvastatin 13CD3 is chemically (1S,3S,7R,8R)-8-(2-((2S,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methyl-2-(methyl-13C-d3)butanoate. Simvastatin 13CD3 is supplied with detailed characterization data compliant with regulatory guideline. Simvastatin 13CD3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Simvastatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1261364-93-5
Purchase 1261364-93-5
Order 1261364-93-5
Enquire 1261364-93-5
price of 1261364-93-5
1261364-93-5 Supplier
1261364-93-5 Manufacturer
1261364-93-5 Exporter
buy high quality Simvastatin 13CD3
Purchase Simvastatin 13CD3
Simvastatin 13CD3 suppliers
Simvastatin 13CD3 manufacturers
Simvastatin 13CD3 price
Order Simvastatin 13CD3
Enquire Simvastatin 13CD3
Simvastatin 13CD3 cost
Simvastatin 13CD3 Supplier
Simvastatin 13CD3 Distributor
Simvastatin 13CD3 for Method Validation
Simvastatin Reference Standard
Simvastatin 13CD3 for ANDA Filing
Simvastatin 13CD3 for Forced Degradation Studies
Simvastatin 13CD3 Identification Standards
Simvastatin 13CD3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.